With an ageing population and an increasing number of primary arthroplasties performed, the revision burden is predicted to increase. The aims of this study were to 1. Determine the revision burden in an academic hospital over a 11-year period; 2. identify the direct hospital cost associated with the delivery of revision service and 3. ascertain factors associated with increased cost.

This is an IRB-approved, retrospective, single tertiary referral center, consecutive case series. Using the hospital data warehouse, all patients that underwent revision hip or knee arthroplasty surgery between 2008-2018 were identified. 1632 revisions were identified (1304 patients), consisting of 1061 hip and 571 knee revisions. The majority of revisions were performed for mechanical-related problems and aseptic loosening (n=903; 55.3%); followed by periprosthetic joint infection (n=553; 33.9%) and periprosthetic fractures (176; 10.8%). Cost and length of stay was determined for all patient. The direct in-hospital costs were converted to 2020 inflation-adjusted Canadian dollars. Several patients- (age; gender; HOMR- and ASA-scores; Hemoglobin level) and surgical- (indication for surgery; surgical site) factors were tested for possible associations.

The number of revisions increased by 210% in the study period (2008 vs. 2018: 83 vs. 174). Revision indications changed over study period; with prevalence of fracture increasing by 460% (5 in 2008 vs. 23 in 2018) with an accompanying reduction in mechanical-related reasons, whilst revisions for infection remained constant. The mean annual cost over the entire study period was 3.9 MMCAD (range:2.4–5.1 MMCAD). The cost raised 150% over the study period from 2.4 MMCAD in 2008 to 3.6 MMCAD. Revisions for fractured had the greatest length of stay, the highest mean age, HOMR-score, ASA and cost associated with treatment compared to other revision indications (p < 0 .001). Patient factors associated with cost and length of stay included ASA- and HOMR-scores, Charlson-Comorbidity score and age.

The revision burden increased 1.5-fold over the years and so has the direct cost of care delivery. The increased cost is primarily related to the prolonged hospital stay and increased surgical cost. For tertiary care units, these findings indicate a need to identify strategies on improving efficiencies whilst improving the quality of patient care (e.g. efficient ways of reducing acute hospital stay) and reducing the raise of the economic burden on a publicly funded health system.

The reconstruction of peri-acetabular defects after severe bone loss or pelvic resection for tumor is among the most challenging surgical intervention. The Lumic® prosthesis (Implantcast, Buxtehude, Germany) was first introduced in 2008 in an effort to reduce the mechanical complications encountered with the classic peri-acetabular reconstruction techniques and to improve functional outcomes. Few have evaluated the results associated with the use of this recent implant.

A retrospective study from five Orthopedic Oncology Canadian centers was conducted. Every patient in whom a Lumic® endoprosthesis was used for reconstruction after peri-acetabular resection or severe bone loss with a minimal follow-up of three months was included. The charts were reviewed and data concerning patients’ demographics, peri-operative characteristics and post-operative complications was collected. Surgical and functional outcomes were also assessed.

Sixteen patients, 11 males and five females, were included and were followed for 28 months [3 – 60]. Mean age was 55 [17–86], and mean BMI reached 28 [19.6 – 44]. Twelve patients (75%) had a Lumic® after a resection of a primary sarcoma, two following pelvic metastasis, one for a benign tumor and one after a comminuted acetabular fracture with bone loss. Twelve patients (75%) had their surgery performed in one stage whereas four had a planned two-stage procedure. Mean surgical time was 555 minutes [173-1230] and blood loss averaged 2100 mL [500-5000]. MSTS score mean was 60.3 preoperatively [37.1 – 97] and 54.3 postoperatively [17.1-88.6]. Five patients (31.3%) had a cemented Lumic® stem. All patients got the dual mobility bearing, and 10 patients (62.5%) had the largest acetabular cup implanted (60 mm). In seven of these 10 patients the silver coated implant was used to minimize risk of infection. Five patients (31.3%) underwent capsular reconstruction using a synthetic fabric aiming to reduce the dislocation risk. Five patients had per-operative complications (31.3%), four were minor and one was serious (comminuted iliac bone fracture requiring internal fixation). Four patients dislocated within a month post-operatively and one additional patient sustained a dislocation one year post-operatively. Eight patients (50%) had a post-operative surgical site infection. All four patients who had a two-stage surgery had an infection. Ten patients (62.5%) needed a reoperation (two for fabric insertion, five for wash-outs, and three for implant exchange/removal). One patient (6.3%) had a septic loosening three years after surgery. At the time of data collection, 13 patients (81.3%) were alive with nine free of disease. Silver coating was not found to reduce infection risk (p=0.2) and capsuloplasty did not prevent dislocation (p=1).

These results are comparable to the sparse data published. Lumic® endoprosthesis is therefore shown to provide good functional outcomes and low rates of loosening on short to medium term follow-up. Infection and dislocation are common complications but we were unable to show benefits of capsuloplasty and of the use of silver coated implants. Larger series and longer follow-ups are needed.

Short cementless femoral stems are increasingly popular as they allow for less dissection for insertion. Use of such stems with the anterior approach (AA) may be associated with considerable per-operative fracture risk. This study's primary aim was to evaluate whether patient-specific femoral- and pelvic- morphology and surgical technique, influence per-operative fracture risk. In doing so, we aimed to describe important anatomical thresholds alerting surgeons.

This is a single-center, multi-surgeon retrospective, case-control matched study. Of 1145 primary THAs with a short, cementless stem inserted via the AA, 39 periprosthetic fractures (3.4%) were identified. These were matched for factors known to increase fracture risk (age, gender, BMI, side, Dorr classification, stem offset and indication for surgery) with 78 THAs that did not sustain a fracture. Radiographic analysis was performed using validated software to measure femoral- (canal flare index [CFI], morphological cortical index [MCI], calcar-calcar ratio [CCR]) and pelvic- (Ilium-ischial ratio [IIR], ilium overhang, and ASIS to greater trochanter distance) morphologies and surgical technique (% canal fill). Multivariate and Receiver-Operator Curve (ROC) analysis was performed to identify predictors of fracture.

Femoral factors that differed included CFI (3.7±0.6 vs 2.9±0.4, p3.17 and II ratio>3 (OR:29.2 95%CI: 9.5–89.9, p<0.001).

Patient-specific anatomical parameters are important predictors of fracture-risk. When considering the use of short stems via the AA, careful radiographic analysis would help identify those at risk in order to consider alternative stem options.

The reconstruction of peri-acetabular defects after severe bone loss or pelvic resection for tumor is among the most challenging surgical intervention. The Lumic® prosthesis (Implantcast, Buxtehude, Germany) was first introduced in 2008 in an effort to reduce the mechanical complications encountered with the classic peri-acetabular reconstruction techniques and to improve functional outcomes. Few have evaluated the results associated with the use of this recent implant.

A retrospective study from five Orthopedic Oncology Canadian centers was conducted. Every patient in whom a Lumic® endoprosthesis was used for reconstruction after peri-acetabular resection or severe bone loss with a minimal follow-up of three months was included. The charts were reviewed and data concerning patients’ demographics, peri-operative characteristics and post-operative complications was collected. Surgical and functional outcomes were also assessed.

Sixteen patients, 11 males and five females, were included and were followed for 28 months [3 – 60]. Mean age was 55 [17-86], and mean BMI reached 28 [19.6 – 44]. Twelve patients (75%) had a Lumic® after a resection of a primary sarcoma, two following pelvic metastasis, one for a benign tumor and one after a comminuted acetabular fracture with bone loss. Twelve patients (75%) had their surgery performed in one stage whereas four had a planned two-stage procedure. Mean surgical time was 555 minutes [173-1230] and blood loss averaged 2100 mL [500-5000]. MSTS score mean was 60.3 preoperatively [37.1 – 97] and 54.3 postoperatively [17.1-88.6]. Five patients (31.3%) had a cemented Lumic® stem. All patients got the dual mobility bearing, and 10 patients (62.5%) had the largest acetabular cup implanted (60 mm). In seven of these 10 patients the silver coated implant was used to minimize risk of infection. Five patients (31.3%) underwent capsular reconstruction using a synthetic fabric aiming to reduce the dislocation risk. Five patients had per-operative complications (31.3%), four were minor and one was serious (comminuted iliac bone fracture requiring internal fixation). Four patients dislocated within a month post-operatively and one additional patient sustained a dislocation one year post-operatively. Eight patients (50%) had a post-operative surgical site infection. All four patients who had a two-stage surgery had an infection. Ten patients (62.5%) needed a reoperation (two for fabric insertion, five for wash-outs, and three for implant exchange/removal). One patient (6.3%) had a septic loosening three years after surgery. At the time of data collection, 13 patients (81.3%) were alive with nine free of disease. Silver coating was not found to reduce infection risk (p=0.2) and capsuloplasty did not prevent dislocation (p=1).

These results are comparable to the sparse data published. Lumic® endoprosthesis is therefore shown to provide good functional outcomes and low rates of loosening on short to medium term follow-up. Infection and dislocation are common complications but we were unable to show benefits of capsuloplasty and of the use of silver coated implants. Larger series and longer follow-ups are needed.

Over 62,000 total hip arthroplasty (THA) cases are performed each year in Canada, with an estimated annual healthcare system cost of $1.4 billion and resulting in 4 billion tonnes of waste annually (6,600 tonnes per day). The aims of this study were 1) Assess satisfaction of current/standard set-up amongst different stakeholders. 2) Assess energy, economic and waste cost of current set up and apply lean methodology to improve efficiency 3. Design and test SLIM setup based on lean principles and its ability to be safely implemented into everyday practice.

A Needs Assessment Survey was circulated to OR nursing staff to assess the need for change in the current THA OR setup at an academic tertiary referral hospital. Through feedback, surgeon input, and careful analysis of current instrumentation, the “SLIM setup” was created. Standard instrument tray numbers for elective THA were reduced from 9 to 3 trays. Eighty patients were then randomised to either the standard or SLIM setup. Four staff arthroplasty surgeons each randomised 20 patients to either standard or SLIM setup. OR time, blood loss, 90-day complication rates, cost/case, instrument weight (kg/case), total waste in kg/case (non-recyclable), case set-up time, and number of times and number of extra trays required were compared between groups.

The majority of nursing staff demonstrated dissatisfaction with the current THA setup and felt current processes lacked efficiency. Use of the SLIM setup, was associated with the following savings in comparison to standard (Trays = −6 (720kg/case); Waste = −1.5 kg/case; Cost = − $560 ($50.00 × 6 trays + 10min saved × $26.00 /min OR setup time)). OR time, blood loss and 90-day complication rate were not statistically different (p >0.05); however, set up time was significantly shorter in comparison to standard. Extra instrumentation was opened in < 10% of cases.

A more minimalist approach to THA can be undertaken using the SLIM setup, potentially resulting in cost, energy and waste savings. Estimate savings of $560,000 and 1.65 tonnes reduction in waste per 1,000 THAs performed may be realised.

The Oxford mobile bearing knee prosthesis (Zimmer Biomet Inc, Warsaw, Ind) is considered a good treatment option for isolated medial compartment knee arthrosis. From February 2001 until August 2016, 1719 primary Oxford medial unicompartmental knee replacement procedures were completed at our center by a group of seven surgeons. We undertook this study to examine the long-term survivorship of the Oxford unicompartmental knee replacement looking at survivorship and reasons for failure.

A retrospective consecutive case series review was completed, and all revisions and re-operations were identified. Conversion to total knee replacement (TKA) was considered a failure. Kaplan-Meier survival analysis was used to calculate the 15-year survivorship of the group overall. We specifically looked at age, gender, BMI and surgeon caseload in addition to the reasons for failure. A statistical analysis was performed and differences in survivorship were compared for the variables listed. A logistic cox regression was performed to explore predictors of revision.

Overall 15-year survivorship was 89.9%. Female survivorship of 88.1% was statistically worse than the male group at 91.8% (p=0.018). Younger patients (75yrs of age (p= 0.036). There was a large range in surgical case load by individual surgeons (range 17–570 knees). There were no statistically significant differences in age, BMI, or gender when comparing the individual surgeon groups. There was a large range in 15-year survivorship between individual surgeons (range 78.3% – 95%). Overall the most common reason for revision was due to wear of the unreplaced portion of the knee (lateral and/or patella-femoral joint) followed by aseptic loosening, polyethylene dislocation, infection or persistent pain.

The 15-year survivorship results of the Oxford medial unicompartmental knee replacement at our center compares favourably to other published series and large registry data series. We found a reduction in survivorship in female patients and younger patients (< 5 5yrs). There were also significant differences in survivorship based on the individual surgeon. A more selective patient approach yielded the best long-term survivorship and equivalent to that of total knee replacement. We therefore suggest using a more selective approach when choosing patients for a medial unicompartmental knee replacement with the Oxford mobile bearing prosthesis in order to enhance long-term survivorship.

The effectiveness of total hip replacement as a surgical intervention has revolutionized the care of degenerative conditions of the hip joint. However, the surgeon is still left with important decisions in regards to how best deliver that care with choice of surgical approach being one of them especially in regards to the short-term clinical outcome. It is however unclear if a particular surgical approach offers a long-term advantage. This study aims to determine the influence of the three main surgical approaches to the hip on patient reported outcomes and quality of life after 5 years post-surgery.

We extracted from our prospective database all the patients who underwent a Total Hip Replacement surgery for osteoarthritis or osteonecrosis between 2008 and 2012 by an anterior, posterior or lateral approach. All the pre-operative and post-operative HOOS (Hip disability and Osteoarthritis Outcome Score) and WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) scores were noted. Analysis of covariance (ANCOVAs) were used to study the relationship between amount of change in HOOS and WOMAC subscales (dependant variables) and approach used, by also including confounding factors of age, gender, ASA (American Society of Anaesthesiologists) score, Charnley score and Body Mass Index. A total of 1895 patients underwent a primary total hip arthroplasty during the considered period. Among them, 367 had pre-operative and ≥5 years post operative PROM scores (19.47%)

The mean follow-up for the study cohort was 5.3 years (range 5 to 7 years) with, 277 at 5 years, 63 at 6 years, and 27 at 7 years. In the posterior approach group we had 138 patients (37.60%), 104 in the lateral approach (28.34%) and 125 in the anterior approach (34.06%). There were no significant differences between the 3 groups concerning the Charnley classification, BMI, Gender, ASA score, side and pre-operative functional scores. We did not observe any significant difference in the amount of change in HOOS and WOMAC subscales between the 3 groups. There were no differences either in the post-operative scores in ultimate value.

Our monocentric observational study shows that these three approaches provide predictable and comparable outcomes on HRQL and PROMs at long-term follow-up both in terms of final outcome but also in percent improvement. This study has several limitations. We excluded patients who underwent revision surgery leaving the unanswered question of how choice of surgical approach could lead to different revision rates, which have an impact on the functional outcomes. Moreover, even if we controlled for the most important confounders by a multivariate analysis model, there is still some involved cofounders, which could potentially lead to a bias such as smoking, socio-economical status or femoral head diameter. But we do not have any reason to think that these parameters could be unequally distributed between the three groups. Finally, our study cohort represents of 19.47% of the complete cohort. The fact that not all patients have PROM's was pre-determined as eight years ago we instituted that only 1 in 5 patients that returned their pre-operative questionnaire would get their PROM's at follow-up. Despite this, our statistical power was sufficient.

Introduction

The mechanisms of how spinal arthrodesis (SA) affects patient function after total hip replacement (THA) remain unclear. The objectives of this study were to a) Determine how outcome post-THA compares between patients with- and without-SA, b) Characterize sagittal pelvic changes that occur when moving between different functional positions, and test for differences between patients with- and without-SA, and c) Assess whether differences in sagittal pelvic dynamics are associated with outcome post-THA.

The incidence of lateral femoral cutaneous nerve (LFCN) neuropraxia after anterior approach total hip arthroplasty has been reported to occur in up to 50% of patients. In the vast majority of cases there has been no functional impact it is unknown if symptoms persist or diminish over time. The aim of this study was to examine the natural history LFCN neuropraxia in a previously reported cohort of individuals after anterior approach total hip arthroplasty.

One hundred and forty three consecutive patients underwent direct anterior hip approach (DAA) between September 2006 and February 2009 of which 107 had been identified with LCFN neuropraxia. These 107 patients (39 THA; 68 HR; 44 Female & 63 male; mean age 55.4 (38.4–88.8)), were provided a self-reported questionnaire for sensory deficits associated with LFCN as well as severity of symptoms on a 10 point visual analogue scale (VAS). These were done at initial assessment and latest follow-up.

Sixty of the 107 patients (56%) completed their questionnaires at a mean follow-up of 5.4 years (24 THA; 36 HR). Twenty-two percent (13 of 60: 8 men & 5 women) had complete resolution of their symptoms (9 HR and 4 THR). Of the 47 patients (78%) still reporting symptoms of LFCN neuropraxia, the mean score on VAS decreased from a mean of 2.32 (SD:2.11) to 1.74 (SD:1.99). No limitation in activities was reported for 90% of patients (54 out of the 60). Of the 6 patients (10%) with limited activity they reported a mean VAS score of 4.4 (SD: 3.6 range of 0–8.4). The LFCN symptoms did not appear to be directly related to their activity limitation.

While LFCN neuropraxia can be a common complication following direct anterior approach hip replacement, almost a quarter of patients will have complete resolution of symptoms and the majority will have a decrease in their symptomatology. LFCN neuropraxia following DAA hip arthroplasty does not appear to lead to any functional limitations and is associated with a low score on VAS.

Introduction

Although femoral neck fractures remain a concern in short term failures for hip resurfacing, acetabular component position and fixation are increasingly being recognized as causes of mid term failures for hip resurfacing. This study aimed to evaluate the migration pattern of a cobalt chrome, beaded acetabular component for a metal on metal hip resurfacing.

Purpose

The purpose of the study was to determine the rate of conversion from RSA to THR in a number of Canadian centers performing resurfacings

Purpose: Although femoral neck fractures remain a concern in terms of short term failures for hip resurfacing, acetabular component position and fixation are increasingly being recognized as causes of mid term failures for hip resurfacing. The purpose of our study was to evaluate the migration pattern of a cementless acetabular component for a metal on metal hip resurfacing.

Method: Between January 2006 and June 2007, 130 patients underwent metal on metal hip resurfacing; 66 hips in 60 patients were included in this analysis. Forty-eight patients were male and 12 were female, with a mean age of 50 (range, 32–66). Ninety-five percent of the surgeries were performed for osteoarthritis. All surgeries were performed by two surgeons using the Conserve Plus (Wright Medical Technology, Memphis, TN) hip resurfacing system. The acetabular component is a monoblock cobalt chrome with a porous beaded surface for osteointegration. In all cases acetabular migration was measured both vertically and horizontally, on serial radiographs using the computer-assisted Ein Bild Röntgen Analyse (EBRA) method. A minimum of three comparable radiographs is necessary for calculating the migration curves. We scored medial migration as negative horizontal movement.

Results: At a mean follow up 25.3 months (range, 24–36 months), each hip had an average of 5.1 radiographs for analysis. The software excluded two cases for poor comparability ending finally with 64 cases for the analysis. Eighty-seven point five per cent of the cups showed less than 1 mm migration in the medium-lateral axis and 54.7% less than 1 mm in the vertical axis. Seventy-seven percent of the cups showed a combined migration of less than 2 mm in the observation period, without radiolucencies, leaving 23% of the acetabular components with 2 mm or greater of component migration. One of these cases required revision for aseptic loosening at 34 months.

Conclusion: In our study the majority of the acetabular components were stable with some of the migration observed secondary to lack of complete initial seating due to the rigidity of the shell. Krismer et al did report on the migration of the PCA shell (also a porous beaded cobalt-chrome shell) using EBRA, with 27.5% of the shells demonstrating > 1 mm of migration. Although hip resurfacing has only mid term followup, results have been good to excellent. Caution should still be maintained since the higher frictional torque generated by the larger femoral head size as well as the nanometer size particles could negatively affect long term fixation of the acetabular component.

Purpose: To determine if early functional assessment correlates and/or predicts long term function after hemi-arthroplasty for displaced femoral neck fractures.

Method: We evaluated prospectively fifty six (56) patients with Garden-type III and IV femoral neck fractures in a Level 1 trauma center with a minimum of two years follow-up. Validated functional measures including Lower Extremity Measure (LEM) and Timed Up and Go (TUG) were used. Score progression was recorded and analyzed in relation to patient baseline data.

Results: The regression analysis between TUG times at three months and the mean LEM scores at two years follow-up showed a good correlation (R2=0.659). Further analysis determined that patients with TUG times of less than twenty (20) seconds at six weeks of follow-up had a mean LEM score significantly higher at both one year (81.5 vs 56.2; p< 0.001) and two years follow-up (77.1 vs 41.8; p< 0.001). This difference between mean LEM scores was also noted for the TUG values at three months.

Conclusion: The TUG test is an early clinical indicator of future function. Innovative clinical approaches such as the one demonstrated in this study to anticipate future function will contribute to increasing efficiency in the overall management of this growing patient population.

Hip resurfacing arthroplasty has become a popular treatment option for younger active patients. The early published results from designing surgeons/centers have been favourable. We undertook a prospective multi-center trial to determine the outcome of hip resurfacing arthroplasty at independent centers. The clinical, radiographic and functional results were assessed.

A prospective IRB approved study was initiated in July 2003 to assess the outcome of hip resurfacing arthroplasty using a contemporary design implant. (Conserve Plus - Wright Medical Technology) Disease specific (Harris Hip Score/WOMAC) and global (Rand self assessment index) outcome measures were used. Radiographs were reviewed for component position and migration as well as any signs of lysis or loosening. Complications and re-operations were recorded.

A total of one hundred and eighty-eight patients have been enrolled in the study to date. One hundred and four patients have a minimum one year follow-up and forty-six patients have a minimum two year follow-up. Mean Harris Hip Scores (pre-op, one year, two years) were fifty-five, eighty-nine and ninety-one. Mean WOMAC pain scores were forty-seven, ninety and ninety. Mean WOMAC stiffness scores were forty, seventy-eight and eighty-two. Mean WOMAC function scores were forty-six, eighty-seven and eighty. RAND physical function mean scores were thirty-three, seventy-six and seventy-six and the RAND physical limitations mean scores were nineteen, sixty-seven and seventy-five. Radiographic analysis showed average cup abduction to be forty-six degrees (range twenty-six to sixty-three). Average femoral stem position was one hundred and thiry-eight degrees (range one hundred and eighteen to one hundred and fifty-seven). Nine patients have been revised to date (4.8%). Four for acetabular loosening, two for neck fracture, one for femoral loosening, one for impingement and one for persistent pain. There have been eight other patients requiring re-operation without revision. Medical complications occurred in fifteen patients.

Early results have demonstrated a good return of function in patients with hip resurfacing arthroplasty. A high early revision rate (4.8%) was seen in our study. Technical factors appear to be the main contributor to the high early complication rate. Hip resurfacing is associated with a steep learning curve. We continue to utilise hip resurfacing in select patients but recommend caution for those who are new to the technique.

Cementless femoral fixation is the gold standard in revision hip arthroplasty. Distal fixation is achieved using either a cobalt chrome or titanium stem. The purpose of this study is to report the long-term survivorship and clinical outcome of a titanium, long-stemmed, load-bearing calcar-replacement femoral component from an independent centre.

Eighty-one patients (average seventy-four years, range thirty-five to ninety-one) underwent hip arthroplasty with the Mallory-Head calcar-replacement femoral component, by a single surgeon. There were thirty-eight males and forty-three females with fifty-four hips initially revised for aseptic loosening, thirteen for peri-prosthetic fracture, and five for infection as a two-stage procedure. The implant was used as a primary device in eight patients with deformed proximal femurs. At most-recent follow-up, radiographic analysis was conducted and clinical outcome scoring was assessed using the SF-12, Harris Hip Score, and WOMAC questionnaire for surviving patients. Complications were also reviewed.

At a mean follow-up of 7.4 years (range four to fifteen), eight patients have died. There was one deep infection, three DVT’s, and two dislocations in the perioperative period. Six femoral stems have ultimately required another revision surgery for aseptic loosening, two for infection, and 1 for implant fracture at a mean of 5.6 years after initial revision. Four patients required removal of the proximal trochanteric bolt due to breakage or loosening. Overall survival of the implant at five years is 95% (CI 0.87–0.98) and 87% (CI 0.72–0.94) at ten years.

The clinical outcome of the Mallory-Head calcar-replacement femoral revision stem is reported from an independent centre. Although the results are encouraging, it would appear that proximal load-bearing fixation with the calcar-replacement stem is not as reliable as distal fixation. The use of a trochanteric bolt was associated with fracture of the greater trochanter or need for a separate surgical procedure for removal. For this series, there was an overall 11% failure rate at a mean follow-up of 7.4 years. The mechanical failure rate is 7.4%. Our overall and mechanical failure rates are somewhat higher than those of the implant developers, who reported 94% overall survival, and a 1.9% mechanical failure rate at a mean follow-up of eleven years.

Metal on metal hip articulations are associated with the release of cobalt and chromium ions. There are few published reports of these levels following hip resurfacing arthroplasty. This study was undertaken to determine cobalt and chromium ion levels following hip resurfacing arthroplasty.

Ninety-one patients were prospectively entered in a study assessing ion levels following hip resurfacing arthroplasty. Serum, erythrocyte and urine cobalt and chromium levels were measured. Samples were collected preoperatively then at three months, six months and yearly thereafter. Each sample was analyzed with an ICPMS assay machine.

Preoperatively the median values for serum, erythrocyte and urine cobalt and chromium levels were all within the normal range. Median serum cobalt levels increased from baseline (0.1 ug/l) to 1.1 ug/l at one year and 1.6 ug/l at two years. Median serum chromium levels increased from baseline (0.2 ug/l) to 1.9 ug/l at one year and 3.3 ug/l at two years. Median erythrocyte cobalt levels increased from baseline (0.1 ug/l) to 1.0 ug/l at one year and 1.3 ug/l at two years. Median erythrocyte chromium levels increased slightly from baseline (1.0 ug/l) to 1.2 ug/l at both one and two year follow-up. No correlation was seen between ion levels and patient activity, implant position, clinical scores or BMI. No clinical effects of elevated ions were observed. Outliers of either cobalt or chromium were seen in twelve patients (13%) in the series.

Hip resurfacing arthroplasty is associated with significant elevations of cobalt and chromium ions. An increase in serum levels of both cobalt and chromium has been noted at two years. This trend also occurs with erythrocyte cobalt but not with erythrocyte chromium. There is a close correlation between serum and erythrocyte cobalt levels but not between serum and erythrocyte chromium levels. We recommend using serum cobalt and serum chromium measurements as a standardised method of ion analysis following metal on metal hip replacement. This allows for capture of maximal levels of both ions in vivo. Further study is required to determine if any clinical effect will be seen as a result of these elevated ions.

The purpose of the present study is to report the failure rate after total knee replacements performed with poly-ethylene inserts that had been sterilized with gamma irradiation in air and implanted after a prolonged shelf life. 395 PFC total knees were performed using polyethylene that had been sterilized by gamma irradiation in air. Shelf life of all polyethylene inserts was determined from manufacturer data. A Chi-square test revealed that the proportion of implants that required a revision for polyethylene failure was related to the number of years that the implant had been stored on the shelf.

Report failure rate of PFC total knee replacements performed with polyethylene sterilized by gamma irradiation in air and implanted after a prolonged shelf life.

There was an increased revision rate in total knees with polyethylene sterilized by gamma irradiation in air and implanted after a shelf life greater than two years.

Polyethylene sterilized by gamma irradiation in air should not be implanted after a shelf life of greater than two years.

Ten of twelve revisions had polyethylene inserts with a shelf life greater than two years. A Chi-square test revealed that the proportion of implants that required a revision was related to the number of years that the implant had been on the shelf, particularly if greater than two years χ² (1)=7.427, p=.006

395 PFC total knees were performed using polyethylene sterilized by gamma irradiation in air. Shelf life of all polyethylene inserts was determined from manufacturer data. A retrospective review was undertaken to determine which patients underwent revision surgery as a result of aseptic loosening secondary to polyethylene failure. The data was then used to determine the relationship between shelf life and revision status.

The mechanical toughness of polyethylene that has been sterilized by gamma irradiation in air decreases with a prolonged shelf life. This results in an unacceptably high revision rate. We therefore recommend against the use of polyethylene that has been gamma irradiated in air and stored for greater than two years on the shelf.

Funding: This study has been sponsored in part by Johnson& Johnson/Depuy Orthopedics.

Purpose: A multicenter prospective evaluation of the Conserve Plus resurfacing implant (Wright Medical Technology) was undertaken to assess clinical and radiographic outcomes as well as ion levels. This study focuses on the serum, erythrocyte and urinary levels of cobalt and chromium in those patients undergoing hip resurfacing arthroplasty.

Methods: A subset of patients enrolled in a multicenter trial to assess hip resurfacing arthroplasty had serum, erythrocyte and urinary cobalt and chromium levels measured. Levels were assessed preoperatively, then at three months, six months then yearly thereafter. Clinical outcome measurements were performed with WOMAC and Rand questionnaires.

Results: Fifty-four out of 124 patients enrolled in the overall study had cobalt and chromium ion assessments performed. During the first year there was an increase in serum cobalt levels from 1.4 ug/l at 3 months to 2.4 ug/l at one year. Serum chromium levels increased from 1.4 ug/l at 3 months to 3.5 ug/l at one year. Erythrocyte cobalt levels increased from 0.8 ug/l at 3 months to 1.4 ug/l at one year. Erythrocyte chromium levels decreased from 1.5 ug/l at 3 months to 1.4 ug/l at one year. Urinary levels for cobalt increased from 12.7 ug/l at 3 months to 13.8 ug/l at one year. Urinary chromium levels rose from 4.0 ug/l at 3 months to 5.1 ug/l at one year.

Conclusions: Increasing ion levels were seen during the first year post hip resurfacing arthroplasty. Clinical outcomes demonstrate predictable improvements in pain and function consistent with hip replacement surgery. Resurfacing arthroplasty is a viable option to total hip arthroplasty for younger active patients. The clinical significance of increased cobalt and chromium ions remains unknown. Funding: Commerical funding Funding Parties: Wright Medical Technology Inc.

This study evaluates metal ion levels in patients enrolled in a prospective evaluation of hip resurfacing arthroplasty utilizing the Conserve Plus implant (Wright Medical Technology). Serum, urine and erythrocyte metal ion levels were assessed preoperatively and postoperatively. Average levels at three months were 24 nmol/l for cobalt and 40 nmol/l for chromium. These increased to 40 nmol/l for cobalt and 80 nmol/l for chromium at the six-month mark. The clinical significance of increased metal ion levels is yet to be determined.

To evaluate the clinical, functional and radiographic outcome of hip resurfacing arthroplasty utilizing the Conserve Plus implant (Wright Medical Technology). Serum, urine and erythrocyte metal ion levels were evaluated both pre and postoperatively.

Ion levels for both cobalt and chromium increased from the three-month to the six-month mark postoperatively and were significantly elevated relative to preoperative values.

This study helps to establish a baseline for metal ion levels following hip resurfacing arthroplasty.

Serum, urine and erythrocyte metal ion levels were assessed preoperatively and postoperatively. All levels were within normal range preoperatively. Average serum levels at three months were 24 nmol/l for cobalt and 40 nmol/l for chromium. These increased to 40 nmol/l for cobalt and 80 nmol/l for chromium at the six-month mark. Average erythrocyte metal ion levels at three months were 0.92 ug/l for cobalt and 1.8 ug/l for chromium. The average erythrocyte levels at six months were 1.3 ug/l for cobalt and 2.0 ug/l for chromium.

A prospective multi-center study to evaluate the outcome of hip resurfacing arthroplasty was initiated in July 2003. Each patient was evaluated preoperatively and postoperatively with outcome scores, radiographs as well as serum, urine and erythrocyte metal ion levels.

The results of this prospective evaluation show a rise in ion levels from three to six months postoperatively. Further follow-up is necessary to assess future trends with respect to the ion levels as well as the clinical significance.

Funding: This study has been sponsored in part by Wright Medical Technology.

The purpose of the study was to evaluate the outcome of curettage and grafting with calcium sulfate pellets for progressive retroacetabular osteolysis with retention of the acetabular component. Seven patients who underwent the procedure were evaluated clinically and radiographically at an average follow-up time of fifteen months. There was no progression of osteolysis following curettage and grafting with good to excellent osseo-integration. All patients had a good functional outcome with no pain during follow-up. Curettage and synthetic grafting of retroacetabular cysts with calcium sulfate pellets is a viable option in halting the progression of retroacetabular lysis and promoting osseous recovery.

The purpose of this study was to evaluate outcome of curettage and grafting of progressive retroacetabular osteolysis with calcium sulfate pellets and retention of components.

Restoration of retroacetabular bone stock by curettage and grafting with synthetics would obviate the need for autogenous bone graft and its associated risks. Retention of well-fixed acetabular components also aids in prevention of further bone loss associated with component extraction.

We conducted a clinical and radiographic review of seven patients who presented to the senior author with radiographic findings of progressive retroacetabular osteolysis. All patients were treated with curettage and filling of the defects with calcium sulfate.

Mean follow-up time is fifteen (five to twenty-seven) months. Polyethylene wear was noted in all cases. The size of the lesions ranged from 3.1 x 2.0 to 9.0 x 5.3 cm. On follow-up evaluation, there was no recurrence or progression of the lesions. Osseo-integration was excellent in four cases and good in three cases. All patients had returned to normal level of function with no pain.

Patients with retroacetabular osteolysis are often asymptomatic until catastrophic failure occurs as a result of extensive bone loss. Treatment of retroacetabular osteolysis in the setting of well-fixed components is controversial. Retention of the components, curettage and synthetic grafting with calcium sulfate is a viable option to prevent progression of lysis and stimulate bone formation.

Curettage and grafting of progressive retroacetabular osteolysis with calcium sulfate and retention of components results in good osseo-integration of the graft and halts the progression of lysis.